We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
Cap. Flow
+$445M
Cap. Flow %
0.87%
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.99B
2
MSFT icon
Microsoft
MSFT
+$522M
3
AMD icon
Advanced Micro Devices
AMD
+$511M
4
AMZN icon
Amazon
AMZN
+$318M
5
AAPL icon
Apple
AAPL
+$317M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$402M
2
MCD icon
McDonald's
MCD
+$375M
3
V icon
Visa
V
+$366M
4
META icon
Meta Platforms (Facebook)
META
+$319M
5
ADBE icon
Adobe
ADBE
+$272M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Healthcare 17.11%
3 Consumer Discretionary 13.31%
4 Financials 8%
5 Industrials 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPRE icon
1726
Green Plains
GPRE
$1.06B
$907K ﹤0.01%
28,145
-130,189
-82% -$4.12M
OTECW
1727
CALL
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$907K ﹤0.01%
83,624
-150,000
-64% -$6.86K
SAR icon
1728
Saratoga Investment
SAR
$317M
$905K ﹤0.01%
+33,521
New +$860K
CBZ icon
1729
CBIZ
CBZ
$2.95B
$904K ﹤0.01%
16,961
-1,772
-9% -$91.2K
VTI icon
1730
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$903K ﹤0.01%
4,100
+2,700
+193% +$563K
USCTW
1731
CALL
DELISTED
Roth CH Acquisition Co. Warrant
USCTW
$900K ﹤0.01%
84,968
URGN icon
1732
UroGen Pharma
URGN
$2.26B
$899K ﹤0.01%
86,880
+71,572
+468% +$790K
REVG
1733
DELISTED
REV Group
REVG
$895K ﹤0.01%
+67,520
New +$771K
HNI icon
1734
HNI Corp
HNI
$3.54B
$895K ﹤0.01%
31,751
-19,832
-38% -$527K
CFFSW
1735
CALL
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$890K ﹤0.01%
83,598
BPOP icon
1736
Popular Inc
BPOP
$11.1B
$890K ﹤0.01%
+14,700
New +$866K
TIL icon
1737
Instil Bio
TIL
$50.3M
$889K ﹤0.01%
80,793
F icon
1738
Ford
F
$55.8B
$888K ﹤0.01%
+58,686
New +$742K
RSVRW
1739
CALL
DELISTED
Reservoir Media Inc Warrant
RSVRW
$882K ﹤0.01%
146,519
-3,557
-2% -$5.33K
DORM icon
1740
Dorman Products
DORM
$3.95B
$879K ﹤0.01%
+11,153
New +$939K
CECO icon
1741
Ceco Environmental
CECO
$4.11B
$878K ﹤0.01%
65,740
-13,804
-17% -$172K
BLUA.WS
1742
CALL
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$873K ﹤0.01%
83,328
CHGG icon
1743
Chegg
CHGG
$94.8M
$872K ﹤0.01%
+98,211
New +$1.19M
GGAAW
1744
CALL
DELISTED
Genesis Growth Tech Acquisition Corp. Warrant
GGAAW
$871K ﹤0.01%
74,999
MBSC.WS
1745
CALL
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$871K ﹤0.01%
83,016
BRCC icon
1746
BRC Inc
BRCC
$216M
$870K ﹤0.01%
168,526
-36,210
-18% -$191K
GHL
1747
DELISTED
Greenhill & Co., Inc.
GHL
$869K ﹤0.01%
59,349
-37,637
-39% -$398K
YMAB
1748
DELISTED
Y-mAbs Therapeutics
YMAB
$867K ﹤0.01%
+127,668
New +$957K
MET icon
1749
PUT
MetLife
MET
$61.7B
$865K ﹤0.01%
15,300
-31,500
-67% -$1.75M
GRCL
1750
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$860K ﹤0.01%
+225,628
New +$632K

Similar funds

Marshall Wace's Q2 2023 Portfolio in Review

As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
  • Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
  • Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
  • Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
  • Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
  • Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.